- Lobbying
- Lobbying by International Myeloma Foundation
Lobbying Relationship
Bills mentioned
H.R.2739: Cancer Drug Coverage Parity Act of 2015
Sponsor: Leonard Lance (R-N.J.)
S.1566: Cancer Drug Coverage Parity Act of 2015
Sponsor: Mark Steven Kirk (R-Ill.)
H.RES.174: Expressing support for designation of March as "National Multiple...
Sponsor: Brian Higgins (D-N.Y.)
H.R.1801: Cancer Drug Coverage Parity Act of 2013
Sponsor: Brian Higgins (D-N.Y.)
S.1879: Cancer Treatment Parity Act of 2013
Sponsor: Al Franken (D-Minn.)
H.R.2477: Planning Actively for Cancer Treatment (PACT) Act of 2013
Sponsor: Lois Capps (D-Calif.)
H.R.2827: Part D Beneficiary Appeals Fairness Act
Sponsor: Hank Johnson (D-Ga.)
H.R.543: Blue Water Navy Vietnam Veterans Act of 2013
Sponsor: Chris Gibson (R-N.Y.)
H.R.1491: To authorize the Administrator of the National Oceanic and Atmospheric...
Sponsor: Suzanne Bonamici (D-Ore.)
S.1284: Departments of Labor, Health and Human Services, and Education, and...
Sponsor: Tom Harkin (D-Iowa)
H.R.2410: Agriculture, Rural Development, Food and Drug Administration, and...
Sponsor: Robert B. Aderholt (R-Ala.)
S.1244: Agriculture, Rural Development, Food and Drug Administration, and...
Sponsor: Mark Pryor (D-Ark.)
S.2844: James Zadroga 9/11 Health and Compensation Reauthorization Act
Sponsor: Kirsten E. Gillibrand (D-N.Y.)
H.R.5503: James Zadroga 9/11 Health and Compensation Reauthorization Act
Sponsor: Carolyn B. Maloney (D-N.Y.)
H.R.4800: Agriculture, Rural Development, Food and Drug Administration, and...
Sponsor: Robert B. Aderholt (R-Ala.)
S.2389: Agriculture, Rural Development, Food and Drug Administration, and...
Sponsor: Mark Pryor (D-Ark.)
H.R.83: Consolidated and Further Continuing Appropriations Act, 2015
H.R.3204: Drug Quality and Security Act
Sponsor: Fred Upton (R-Mich.)
S.959: Pharmaceutical Quality, Security, and Accountability Act
Sponsor: Tom Harkin (D-Iowa)
H.R.2746: Cancer Drug Coverage Parity Act of 2011
Sponsor: Brian Higgins (D-N.Y.)
S.3295: Departments of Labor, Health and Human Services, and Education, and...
Sponsor: Tom Harkin (D-Iowa)
H.R.2245: Preserving Access to Life-Saving Medications Act of 2011
Sponsor: Diana DeGette (D-Colo.)
S.296: Preserving Access to Life-Saving Medications Act
Sponsor: Amy Klobuchar (D-Minn.)
S.3187: Food and Drug Administration Safety and Innovation Act
Sponsor: Tom Harkin (D-Iowa)
H.R.4385: Cancer Drug Parity Act of 2021
Sponsor: Brian Higgins (D-N.Y.)
S.3080: Cancer Drug Parity Act of 2021
Sponsor: Tina Smith (D-Minn.)
S.2039: Cancer Drug Parity Act of 2023
Sponsor: Tina Smith (D-Minn.)
H.R.6301: Cancer Drug Parity Act of 2023
Sponsor: Glenn Grothman (R-Wis.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Johanna Gray | Intern, Sen. Barack Obama intern, Sen. Barack Obama |
Jenifer Leib | Policy Fellow, NIH/NHGRI Office of the Director |
Jennifer Leib | Policy Fellow, NIH/NHGRI Office of the Director |
Nicholas G Cavarocchi | n/a |
Nicholas G. Cavarocchi | n/a |
Tiffany Kaszuba | n/a |
Jeremy Scott | n/a |
Lindsey Trischler | n/a |
Grace Kranstover | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
White House Office
Centers For Disease Control & Prevention (CDC)
U.S. Senate
U.S. House of Representatives
White House Office
Centers For Disease Control & Prevention (CDC)
U.S. House of Representatives
White House Office
Centers For Disease Control & Prevention (CDC)
U.S. House of Representatives
White House Office
Centers For Disease Control & Prevention (CDC)
U.S. House of Representatives
White House Office
Centers For Disease Control & Prevention (CDC)
U.S. House of Representatives
White House Office
Centers For Disease Control & Prevention (CDC)
U.S. House of Representatives
White House Office
Centers For Disease Control & Prevention (CDC)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. Senate
U.S. House of Representatives
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Health Issues
U.S. Senate
U.S. Senate
Health Issues
U.S. Senate
U.S. Senate
Health Issues
U.S. Senate
U.S. Senate
Health Issues
U.S. Senate
U.S. Senate
Health Issues
U.S. Senate
U.S. Senate
Health Issues
U.S. Senate
U.S. Senate
Health Issues
U.S. Senate
U.S. Senate
Health Issues
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Natl Institutes of Health (NIH)
Health Issues
U.S. Senate
Natl Institutes of Health (NIH)
Health Issues
U.S. Senate
Natl Institutes of Health (NIH)
Health Issues
U.S. Senate
Natl Institutes of Health (NIH)
Health Issues
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate